Companies: 10,795·Total market cap: $144.5T
Kaleido Biosciences, Inc.

Kaleido Biosciences, Inc.

KLDOOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$4262
P/E Ratio
52W High$0.19
52W Low$0.00001

Kaleido Biosciences, Inc.(KLDO)内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。

SEC EDGAR · FMP · KLDO · 截至 2026年6月8日

活动摘要

买入笔数

0

P-Purchase only

卖出笔数

0

近12个月

买卖比

0.00

Buy/Sell (by trades)

整体情绪

中性
↑ Buy 0%仅显示有效交易 · 排除RSU归属100% Sell ↓

Kaleido Biosciences, Inc.内部人在过去近12个月买卖活动混合。

数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月8日

KLDO 季度内部人买卖趋势

KLDO 内幕交易卖出 · KLDO 内幕交易买入 · 季度活动

买入总量(含股权归属)卖出总量
2.5M1.2M0
2021 Q2
2021 Q3
2021 Q4
2022 Q1

Mobile shows last 4Q · Desktop shows full 8Q

数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 8, 2026

近期内幕交易记录

KLDO 高管卖出股份 · KLDO 董事内幕交易 · SEC Form 4申报

显示最近 23 条 · 普通股 · 仅Form 4

横向滑动查看全部列

Menichella Daniel L

CEO · Director

Purchase

日期

Feb 8

股数

20,000

均价

$11.50

总金额

$230K

View Form 4 on SEC.gov

Flagship Ventures Fund IV General Partner LLC

10 percent owner

Purchase

日期

Feb 8

股数

71,667

均价

$11.50

总金额

$824K

View Form 4 on SEC.gov

Flagship Ventures Fund IV General Partner LLC

10 percent owner

Purchase

日期

Feb 8

股数

71,666

均价

$11.50

总金额

$824K

View Form 4 on SEC.gov

Flagship Ventures Fund IV General Partner LLC

10 percent owner

Purchase

日期

Feb 8

股数

71,667

均价

$11.50

总金额

$824K

View Form 4 on SEC.gov

Flagship Ventures Fund IV General Partner LLC

10 percent owner

Purchase

日期

Jun 4

股数

666,667

均价

$7.50

总金额

$5.00M ⚡

View Form 4 on SEC.gov

Flagship Ventures Fund IV General Partner LLC

10 percent owner

Purchase

日期

Jun 4

股数

666,667

均价

$7.50

总金额

$5.00M ⚡

View Form 4 on SEC.gov

Flagship Ventures Fund IV General Partner LLC

10 percent owner

Purchase

日期

Jun 4

股数

666,666

均价

$7.50

总金额

$5.00M ⚡

View Form 4 on SEC.gov

MELAS KYRIAZI THEO

Director

Purchase

日期

Jun 4

股数

33,333

均价

$7.50

总金额

$250K

View Form 4 on SEC.gov

Flagship Ventures Fund V General Partner LLC

Director

Purchase

日期

Mar 4

股数

333,333

均价

$15.00

总金额

$5.00M ⚡

View Form 4 on SEC.gov

Flagship Ventures Fund V General Partner LLC

Director

Other

日期

Mar 4

股数

625,625

均价

总金额

View Form 4 on SEC.gov

Flagship Ventures Fund V General Partner LLC

Director

Other

日期

Mar 4

股数

964,010

均价

总金额

View Form 4 on SEC.gov

Flagship Ventures Fund V General Partner LLC

Director

Other

日期

Mar 4

股数

4,637,555

均价

$0.00

总金额

$5K

View Form 4 on SEC.gov

Flagship Ventures Fund V General Partner LLC

Director

Purchase

日期

Mar 4

股数

266,667

均价

$15.00

总金额

$4.00M ⚡

View Form 4 on SEC.gov

Flagship Ventures Fund V General Partner LLC

Director

Other

日期

Mar 4

股数

321,337

均价

总金额

View Form 4 on SEC.gov

Flagship Ventures Fund V General Partner LLC

Director

Purchase

日期

Mar 4

股数

333,333

均价

$15.00

总金额

$5.00M ⚡

View Form 4 on SEC.gov

Flagship Ventures Fund V General Partner LLC

Director

Other

日期

Mar 4

股数

426,240

均价

总金额

View Form 4 on SEC.gov

Flagship Ventures Fund V General Partner LLC

Director

Other

日期

Mar 4

股数

625,625

均价

总金额

View Form 4 on SEC.gov

Flagship Ventures Fund V General Partner LLC

Director

Other

日期

Mar 4

股数

1,545,852

均价

$0.00

总金额

$2K

View Form 4 on SEC.gov

Flagship Ventures Fund V General Partner LLC

Director

Other

日期

Mar 4

股数

1,285,347

均价

总金额

View Form 4 on SEC.gov

Flagship Ventures Fund V General Partner LLC

Director

Other

日期

Mar 4

股数

639,360

均价

总金额

View Form 4 on SEC.gov

Flagship Ventures Fund IV General Partner LLC

Director

Other

日期

Mar 4

股数

281,203

均价

总金额

View Form 4 on SEC.gov

Flagship Ventures Fund IV General Partner LLC

Director

Other

日期

Mar 4

股数

665,908

均价

$0.00

总金额

$666

View Form 4 on SEC.gov

Flagship Ventures Fund IV General Partner LLC

Director

Other

日期

Mar 4

股数

173,586

均价

总金额

View Form 4 on SEC.gov

数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 KLDO 内幕交易

KLDO 内幕交易

Kaleido Biosciences, Inc.(KLDO)内幕交易数据来源于公司内部人(包括KLDO)提交的SEC Form 4申报文件。过去12个月内,0位内部人向SEC提交了交易申报。KLDO内部人近期买卖活动混合,这可能反映预设的10b5-1计划执行,而非方向性判断。

如需查看Kaleido Biosciences, Inc.机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →

买卖信号逻辑
acquisitionOrDisposition字段:
A = 买入 · D = 卖出(处置)
RSU归属(M-Exempt)不计入情绪判断
Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件
10b5-1预设交易计划,允许内部人按计划自动卖出
Open Mkt公开市场直接买卖(不含股权奖励和期权行权)

常见问题

KLDO 内幕交易 · 5个问题

Kaleido Biosciences, Inc.(KLDO)的内部人包括高管和董事,如KLDO等。过去12个月内,0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

KLDO 董事内幕交易KLDO 内部人名单Kaleido Biosciences, Inc. 高管内幕活动

数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026